Cefazolin Dosing for Cellulitis
For adults with cellulitis, administer cefazolin 1 gram IV every 8 hours for moderate to severe infections, or 500 mg to 1 gram every 6-8 hours depending on severity. 1, 2 For children beyond the neonatal period, use 33 mg/kg/dose every 8 hours IV. 1
Adult Dosing
The IDSA guidelines and FDA labeling provide clear dosing parameters:
- Moderate to severe infections: 500 mg to 1 gram every 6-8 hours IV 2
- Severe, life-threatening infections: 1 to 1.5 grams every 6 hours IV 2
- Mild infections: 250-500 mg every 8 hours IV 2
The guideline specifically lists 1 gram every 8 hours as the standard dose for non-purulent skin and soft tissue infections in adults 1, which aligns with the FDA-approved dosing for moderate to severe infections.
Special Populations
Patients ≥120 kg: Recent evidence suggests 3 gram dosing may be superior. A 2025 study using modified DOOR methodology showed a 63.7% probability of better outcomes with high-dose (3 g) versus standard-dose cefazolin in patients weighing ≥120 kg (p=0.0471) 3. While not yet in guidelines, this represents the most recent high-quality evidence for this population.
Alternative regimens: For outpatient therapy, twice-daily cefazolin 2 g IV has demonstrated 88% clinical cure rates 4, and once-daily cefazolin 2 g IV plus oral probenecid 1 g achieved 86% cure rates comparable to ceftriaxone 5.
Pediatric Dosing
Standard dose: 33 mg/kg/dose every 8 hours IV 1
For mild to moderately severe infections, the FDA label specifies:
- Total daily dose: 25-50 mg/kg divided into 3-4 equal doses 2
- Severe infections: May increase to 100 mg/kg/day 2
Critical caveat: Cefazolin is not recommended for premature infants and neonates due to lack of safety data 2.
Renal Dose Adjustments
Cefazolin requires careful dose adjustment in renal impairment, as it is primarily renally excreted:
Adults
After an appropriate loading dose 2:
- CrCl ≥55 mL/min or SCr ≤1.5 mg/dL: Full dose, no adjustment needed
- CrCl 35-54 mL/min or SCr 1.6-3.0 mg/dL: Full dose but extend interval to at least every 8 hours
- CrCl 11-34 mL/min or SCr 3.1-4.5 mg/dL: Give ½ usual dose every 12 hours
- CrCl ≤10 mL/min or SCr ≥4.6 mg/dL: Give ½ usual dose every 18-24 hours
Pediatric Patients
After an initial loading dose 2:
- CrCl 70-40 mL/min (mild-moderate impairment): 60% of normal daily dose divided every 12 hours
- CrCl 40-20 mL/min (moderate impairment): 25% of normal daily dose divided every 12 hours
- CrCl 20-5 mL/min (severe impairment): 10% of normal daily dose every 24 hours
Treatment Duration
The IDSA guideline recommends 7 days of therapy for cellulitis, adjusted based on clinical response 1. This duration applies when using appropriate dosing that achieves adequate tissue penetration.
Key Clinical Considerations
Always give a loading dose in renal impairment before implementing reduced maintenance dosing—this ensures adequate initial drug levels 2.
Pharmacokinetic rationale: Cefazolin has a serum half-life of approximately 1.75-2.22 hours in normal renal function 6, which extends significantly in renal impairment, necessitating dose adjustments to prevent accumulation while maintaining efficacy.
Outpatient administration: Cefazolin elastomeric infusers via peripheral IV are safe and well-tolerated, with 88.3% of catheters showing no complications (VIP score = 0) 7, making home-based therapy feasible for appropriate candidates.